|
|
Volumn 46, Issue 1-3, 2000, Pages 103-107
|
|
Part 6: Advanced cardiovascular life support - Section 1: Introduction to ACLS 2000: Overview of recommended changes in ACLS from the Guidelines 2000 Conference
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ADENOSINE;
ADRENALIN;
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
ALTEPLASE;
AMIODARONE;
ANTIARRHYTHMIC AGENT;
ANTITHROMBIN;
ANTITHROMBOCYTIC AGENT;
ARGIPRESSIN;
BENZODIAZEPINE DERIVATIVE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BRETYLIUM;
COCAINE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FIBRINOGEN RECEPTOR ANTAGONIST;
FIBRINOLYTIC AGENT;
HEPARIN DERIVATIVE;
LIDOCAINE;
LOW MOLECULAR WEIGHT HEPARIN;
MAGNESIUM;
NALOXONE;
NITRATE;
OPIATE;
PROCAINAMIDE;
PROUROKINASE;
RETEPLASE;
SOTALOL;
TRICYCLIC ANTIDEPRESSANT AGENT;
ANGIOPLASTY;
ARTIFICIAL VENTILATION;
DEFIBRILLATION;
DRUG INDICATION;
DRUG INDUCED DISEASE;
ELECTROCARDIOGRAPHY;
EVIDENCE BASED MEDICINE;
FIBRINOLYTIC THERAPY;
HEART ARREST;
HEART ARRHYTHMIA;
HEART MUSCLE ISCHEMIA;
HUMAN;
INTOXICATION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RESUSCITATION;
REVIEW;
STROKE;
|
|
EID: 0034705947
PISSN: 03009572
EISSN: None
Source Type: Journal
DOI: 10.1016/S0300-9572(00)00274-4 Document Type: Note |
|
Times cited : (13)
|
|
References (0)
|